Atezolizumab plus bevacizumab in non-clear cell, sarcomatoid kidney cancer

Atezolizumab and Bevacizumab Studied in Patients With Metastatic RCCПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Rana McKay, MD, on recent data examining atezolizumab and bevacizumab in nccRCC & sccRCCПодробнее

Non-clear cell sarcamatoid kidney cancer treatment updatesПодробнее

Dr. Choueiri on Atezolizumab Plus Bevacizumab in Non–Clear Cell RCCПодробнее